Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01178 (
oxytocin
)
15,767
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Neuromedin U
(
NMU
) is a peptide isolated from the porcine spinal cord. Recently, two receptors for
NMU
have been identified and characterized. A recent study indicated that
NMU
is an anorectic chemical in the brain. The present study shows that
NMU
has an action in the brain to inhibit food intake in rats. Intracerebroventricular injection of
NMU
inhibited dark-phase feeding. Animals injected with
NMU
showed a strong increase in Fos-immunoreactive nuclei in the paraventricular nucleus (PVN) and supraoptic nucleus (SON) of the hypothalamus, and in the parabrachial nucleus of the brain stem. Double immunohistochemistry revealed that a high number of
oxytocin
-immunoreactive neurons in the PVN and SON contained Fos after intracerebroventricular injection of
NMU
. In addition, a small proportion of vasopressinergic cells within the PVN and SON were found to contain Fos. The effect of
NMU
on the hypothalamus and brain stem contributes to the inhibitory effects of
NMU
on feeding behavior.
...
PMID:Central administration of neuromedin U activates neurons in ventrobasal hypothalamus and brainstem. 1195 64
Neuromedin U
activates noradrenergic neurones in the medulla oblongata and
oxytocin
neurones in the hypothalamus. Here we examined roles of noradrenergic transmission in
oxytocin
release from the pituitary after intracerebroventricular administration of neuromedin U in rats.
Neuromedin U
administration facilitated noradrenaline release in the supraoptic nucleus. Administration of a beta1 adrenoceptor antagonist, metoprolol, or a beta2 antagonist, ICI 118551 but not an alpha1 antagonist, benoxathian, reduced increases in plasma
oxytocin
concentrations observed after administration of neuromedin U, but plasma ACTH concentrations were not significantly changed. All theses data suggest that neuromedin U stimulates
oxytocin
release from the pituitary, at least in part, via activation of beta adrenoceptors.
...
PMID:Neuromedin U facilitates oxytocin release from the pituitary via beta adrenoceptors. 1456 37